Indian Drugmakers Lose US Pricing Power as Competition Squeezes Margins
Buyer concentration and intensifying competition are squeezing sales and margins. Cipla’s North America revenue fell 19% in rupee terms in the July-September 2026 quarter.
Buyer concentration and intensifying competition are squeezing sales and margins. Cipla’s North America revenue fell 19% in rupee terms in the July-September 2026 quarter.